Tuesday, December 29, 2015 6:09:20 PM
even if you sold after the 14th you are still getting the Dividend
On December 4, 2015, Enzon Pharmaceuticals, Inc. (the “Company”) was advised by NASDAQ that an ex-dividend date of December 30, 2015 has been established for the $0.25 special cash dividend per share that was announced by the Company on December 3, 2015. As previously announced, the $0.25 special cash dividend per share is payable on December 29, 2015 to stockholders of record as of the close of business on December 14, 2015.
On December 4, 2015, Enzon Pharmaceuticals, Inc. (the “Company”) was advised by NASDAQ that an ex-dividend date of December 30, 2015 has been established for the $0.25 special cash dividend per share that was announced by the Company on December 3, 2015. As previously announced, the $0.25 special cash dividend per share is payable on December 29, 2015 to stockholders of record as of the close of business on December 14, 2015.
Recent ENZND News
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 03/27/2026 11:48:34 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/27/2026 12:21:11 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/27/2026 12:19:02 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/27/2026 12:15:50 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/27/2026 12:14:43 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/27/2026 12:13:40 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/27/2026 12:12:33 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/27/2026 12:11:29 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/27/2026 12:10:25 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 09:24:57 PM
